Bottle, mate you have smashed this one out of the park. It's all about CF+ in Q1F18 and absolutely nothing else. I tried to post this weeks ago when I re-posted articles on ADAPT but was cut short due to the announcement, hence why HC is lost and looking in the wrong place, it's all about ADAPT ADAPT ADAPT.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-317
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |